Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
Checkpoint Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Checkpoint Therapeutics reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, two executives at Checkpoint Therapeutics received on average a compensation package of $1.3M, a 201% increase compared to previous year.
Average pay of disclosed executives at Checkpoint Therapeutics
James F. Oliviero III, Chief Executive Officer, received $2.1M in total, which increased by 230% compared to 2017. 61% of Oliviero's compensation, or $1.3M, was in stock awards. Oliviero also received $100K in bonus, $281K in non-equity incentive plan, as well as $450K in salary.
William Garrett Gray, Vice President, Finance and Accounting, received a compensation package of $436K, which increased by 110% compared to previous year. 46% of the compensation package, or $200K, was in stock awards.
Related executives
You may also like
Source: SEC filing on April 30, 2019.